CA Patent

CA2736409A1 — Benzoquinoline inhibitors of vesicular monoamine transporter 2

Assigned to Auspex Pharmaceuticals Inc · Expires 2010-04-22 · 16y expired

What this patent protects

The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2(VMAT2), pharmaceutical compositions thereof, and methods of use thereof.

USPTO Abstract

The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2(VMAT2), pharmaceutical compositions thereof, and methods of use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2736409A1
Jurisdiction
CA
Classification
—
Expires
2010-04-22
Drug substance claim
No
Drug product claim
No
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.